E 212
Pill imprint E 212 has been identified as Mirtazapine 30 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.
Mirtazapine 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Mirtazapine Images
- Imprint:
-
E 212
- Strength:
- 30 mg
- Color:
- Brown
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
FD&C Yellow No. 6
hypromelloses
ferric oxide red
lactose monohydrate
magnesium stearate
polyethylene glycol
polysorbate 80
titanium dioxide
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0212
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67544-0169 | Prepak Systems Inc (repackager) |
| 49999-0630 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Mirtazapine resources
- Mirtazapine (Wolters Kluwer)
- Mirtazapine Orally Disintegrating Tablets (Wolters Kluwer)
- mirtazapine (Cerner Multum)
- Remeron RD (Micromedex) - Includes Dosage Information
- mirtazapine (Micromedex) - Includes Dosage Information
- Mirtazapine (AHFS DI)
- Mirtazapine Orally Disintegrating Tablets (FDA)
- Mirtazapine Tablets (FDA)
- Remeron Tablets (FDA)
- Mirtazapine (Wolters Kluwer)
Search Again
